Fulltext

Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region

Chandran M 1 , Mitchell PJ 2 , Amphansap T 3 , Bhadada SK 4 , Chadha M 5 , Chan DC 6 Show all authors , Chung YS 7 , Ebeling P 8 , Gilchrist N 9 , Habib Khan A 10 , Halbout P 11 , Hew FL 12 , Lan HT 13 , Lau TC 14 , Lee JK 15 , Lekamwasam S 16 , Lyubomirsky G 17 , Mercado-Asis LB 18 , Mithal A 19 , Nguyen TV 20 , Pandey D 21 , Reid IR 22 , Suzuki A 23 , Chit TT 24 , Tiu KL 25 , Valleenukul T 26 , Yung CK 27 , Zhao YL 28 , Asia Pacific Consortium on Osteoporosis (APCO)

Affiliations 

  • 1 Department of Endocrinology, Osteoporosis and Bone Metabolism Unit, Singapore General Hospital, 20, College Road, Academia, Singapore, 169856, Singapore. manju.chandran@singhealth.com.sg
  • 2 Synthesis Medical NZ Limited, Pukekohe, Auckland, New Zealand
  • 3 Department of Orthopedics, Police General Hospital, Bangkok, Thailand
  • 4 Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • 5 Department of Endocrinology, Hinduja Hospital and Research Centre, Mumbai, India
  • 6 Internal Medicine, National University Hospital Chu-Tung Branch, Chinese Taipei, Taiwan
  • 7 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea
  • 8 Department of Medicine in the School of Clinical Sciences, Monash Health, Melbourne, Australia
  • 9 Canterbury District Health Board, Christchurch, New Zealand
  • 10 Section of Chemical Pathology, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan
  • 11 International Osteoporosis Foundation, Nyon, Switzerland
  • 12 Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Malaysia
  • 13 Musculoskeletal and Metabolic Unit, Biomedical Research Center, Pham Ngoc Thach University of Medicine, Bone and Muscle Research Group, Ton Duc Thang University, Ho Chi Minh City, Vietnam
  • 14 Division of Rheumatology, Department of Medicine, National University Hospital, Singapore, Singapore
  • 15 Department of Orthopedics, Beacon International Specialist Centre, Petaling Jaya, Malaysia
  • 16 Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka
  • 17 Osteoporosis Australia, Sydney, Australia
  • 18 Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines
  • 19 Endocrinology, Diabetes Division, Mithal, M. Max Healthcare - Pan-Max, Gurgaon, India
  • 20 Genetics and Epidemiology of Osteoporosis Laboratory, Bone Biology Division, Garvan Institute of Medical Reseach, Sydney, Australia
  • 21 Department of Orthopaedics, National Trauma Centre, Kathmandu, Nepal
  • 22 Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
  • 23 Department of Endocrinology, School of Medicine, Fujita Health University, Toyoake, Japan
  • 24 East Yangon General Hospital, Yangon, Myanmar
  • 25 Polytrauma and Fragility Fracture Team, Department of Orthopaedics and Traumatology, Queen Elizabeth Hospital, Hong Kong, SAR, China
  • 26 Department of Orthopedics, Bhumibol Adulyadej Hospital, Bangkok, Thailand
  • 27 Department of Endocrinology and Patient Safety Unit, Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam
  • 28 Department of Obstetrics and Gynecology, Beijing United Family Hospital, Beijing, China
Osteoporos Int, 2021 Jul;32(7):1277-1278.
PMID: 34043033 DOI: 10.1007/s00198-021-05953-z

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications